Suharno D, West CE, Muhilal, Karyadi D, Hautvast JG
Semaglutide is an FDA-approved GLP-1 receptor agonist geared toward chronic weight management in adults dealing with obesity or who are overweight and have at least one weight-related condition
Unlike traditional systemic drugs that suppress the entire immune system, biologics target specific parts of the immune system
N Engl J Med 2015;372:2387-97.PubMed 651
The Pituitary Society Consensus defined resistance as lack of normalization of prolactin serum levels or lack of relevant mass shrinkage (30% reduction in maximum diameter) when treated with standard dopamine agonist doses (7,5-10mg per day of bromocriptine or 2.0 mg per week of cabergoline) for at least 6 months (45)
Yes, the benefits that come from weight loss, like lower blood pressure and reduced cancer risk, also happen